ANI Pharmaceuticals Inc. (NASDAQ:ANIP)

Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
ANIP Weekly Chart

Old Forum Content for ANIP

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • mharps: $ANIP behaving nicely
  • mharps: $ANIP working
  • mharps: $ANIP adding small
  • mharps: $ANIP rocking
  • Pokersmith: @mharps $ANIP wish I took $ANIP of this one...🙄
  • Forexpro: ...
    Oscar Schafer - $CNK, $ORLY, $COMM, $EVTC, $ANIP

    All the best!

  • RedLeaf1: @Forexpro $XON $MSG $BATRA $MGM $ZBH $CNHI $GCP $PCAR $TXT $ENR $LCRX $HCLP $GTN $ARCC $HOFT $XLE $NTG $BKLN $EWZ $DXJ $EFX $MTN $BFAM $SERV $SHOP $GRUB $OXY $ABBV $MDLZ $MU $WDC $MRVL $ORCL $SNAP $KMX $OEC $OLED $AMAT $SBUX $MLM $MET $CNK $ORLY $COMM $EVTC $ANIP Thanks, Forexpro!
  • indigo1948: @Forexpro $XON $MSG $BATRA $MGM $ZBH $CNHI $GCP $PCAR $TXT $ENR $LCRX $HCLP $GTN $ARCC $HOFT $XLE $NTG $BKLN $EWZ $DXJ $EFX $MTN $BFAM $SERV $SHOP $GRUB $OXY $ABBV $MDLZ $MU $WDC $MRVL $ORCL $SNAP $KMX $OEC $OLED $AMAT $SBUX $MLM $MET $CNK $ORLY $COMM $EVTC $ANIP - thank you for the information - interesting choices - $MDLZ has been channeling for about 2 1/2 years and $OXY has a great deal of room to the upside - long both of these.
  • Gary: ...
    $ANIP – Generic drug company. Very good growth rate. Sales growth accelerating.
    $MYL – bottom at $35.
    $ACRS – Generic. Resistance at 31.80.
    $VRX – another move up on volume
    $AGN – first down day in a while. Protect with ...
  • DAN: ...
    $ANIP -- low-volume breakout from a volatility squeeze. I do not know this company at all. I did some research on it a while back, but really don't remember much about it. Probably too much egg nog. But I'll do some work and let you know my thou ...
  • JoeScreenwriter: @DAN $TSLA $YELP $MLM $PYPL $AVGO $Z $ANIP $UNH $NVDA $ETE #1 $ANIP is ANI Pharmaceuticals Inc, an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals.
  • DAN: @JoeScreenwriter $TSLA $YELP $MLM $PYPL $AVGO $Z $ANIP $UNH $NVDA $ETE #1 Thanks for that, Joe. Really appreciate the info.
  • sierramp: @DAN $TSLA $YELP $MLM $PYPL $AVGO $Z $ANIP $UNH $NVDA $ETE #1 Thank you for this update. I was reluctant to get into $NVDA because it is so far out of the squeeze. I've started a small position with a stop at prior day low for protection. I'm concerned about January also but read your note on that.
  • DAN: @sierramp $TSLA $YELP $MLM $PYPL $AVGO $Z $ANIP $UNH $NVDA $ETE #1 Admittedly not a "safe" buy point because it is so extended. So it is more speculative. Definitely a stock that I'm "chasing." I accept that, and am factoring that into my position size and risk tolerance. Kind of makes me nervous, so I'm not at all being aggressive.
  • issues: @champ $LABU Some of the most amazing down drafts I've seen since 2008; $ANIP (Down 22%) $AKRX (-20%) $DPLO (down 42% in a DAY!) $FIT (-32%) $ENDP (down 20%) These are HUGE losses! For what reason? That the government might scrutinize their drug prices? Crazy. We still hold a large position in $ibb and many drugs stocks. No position in ANIP AKRX DPLO... There is coming a bounce. But how high? It will take years, if ever, to see these come back. We are making some peanuts on $BIS that won't compensate for the huge downdrafts. Wish I had more. I was thinking of LABD but I noticed you think tomorrow it will bounce. I don't know. There may not be a bounce until after the election.
  • Bridget: $ANIP saw a bounce yesterday and now moving lower. ER tomorrow before open.
  • janner0814: ...
    $ANIP - breaking down
    $WB - starting to turn over, toppy
    $PBH- breaking lower
    $FXI - break down, pullback, now moving lower
    $LLY - broke 200MA and now going lower
    $S - looking toppy
    $REN - this big performer is showing signs of slowing down
    $ ...
  • Bridget: $ANIP starting to breakdown after this consolidation. Great performer this year but now getting sold.
  • steve71: $ANIP Cup + Handle over the last eight weeks.
  • steve71: $ANIP Ani outperforming. I have a full position, but would otherwise be adding here.
  • issues: @steve71 $ANIP Do you have a stop in place? Is ANIP a long term hold?
  • steve71: @issues $ANIP Sorry for the delay in answering - timeout for lunch basketball! $ANIP is not a trade for me. Their revenues are growing as their pipeline continues to produce new generics. I DID close the position before last earnings, and will probably do that again. This is in a Roth acct. so short term gains have no tax consequences.
  • steve71: $ANIP Ani climbing as they continue to launch new products.
  • steve71: $ANIP Ani continues working with good volume. This company sells generics. FDA approvals are easy, and they have added eight products this year. No P3 worries here.
  • Bridget: Notes: $SPY - still in the box. Below 212.40 I m bearish, and above 217.50 I'm bullish. In between I remain cautious. $DISH - breakout out of a flag on daily and establishing a new uptrend on the weekly $SWN - breakdown $BOFI - solid breakout then pullback, still think this could run higher $WB - breaking out $JD - almost breaking out $PBR - shot across the bow $SGMS - breakout on the weekly $EFII - new all time high $ANIP - solid uptrending stock $HZN - solid uptrending stock $VBLT - cup formation $CARA - breakout still going $NVDA - move higher on volume $HTZ - breakdown $CLVS - resting $GDDY - good entry point $TRMB - solid uptrend on weekly $BITA - this move is just getting started
  • Kid2old: @Bridget $SPY $DISH $SWN $BOFI $WB $JD $PBR $SGMS $EFII $ANIP $HZN $VBLT $CARA $NVDA $HTZ $CLVS $GDDY $TRMB $BITA I like your recap at the end of the trading day.
  • steve71: $ANIP Adding @ 66.80
  • steve71: $ANIP Ani is behaving well. Higher low respected the 50 dma. Up 3% today. No news. Long.
  • steve71: $ANIP BTO 63.58 Pharma, not biotech. Exited this position in early August, prior to earnings. Shares retreated to the rising 50 dma. Ani buys approved, small market drugs. Last three earnings calls have been "beat and raise." Revenue rapidly growing. Trailing PE 75, but PEG 0.97.
  • issues: @tradeforfamily $ANIK compare to $ANIP, which is too high to buy, but beat .76 to hit .99. POWERFUL MOVE!
  • steve71: $ANIP +9% on earnings.
  • steve71: @woodman $AKRX $ANIP $ACAD Hard to know. I don't see any negatives. But it may be that some bettors were looking for buyout/merger talk and have now moved on. Looks like an opportunity to me. Glad that I sold out 90% of my Akorn position. Not so happy about closing 80% of Ani Pharma... Acadia looks high risk for earnings. I have owned it for eight years, and have learned to avoid earnings. So I shed 90% of that position last week. Acadia may well report a slow take off of Pima sales. Worse, it's about time for them to do another secondary for their multiple P2/P3 trials. And there won't be any buyout talk.
  • woodman: @steve71 $AKRX $ANIP $ACAD I sold all my ACAD the other day. I agree, not in mood to chance that one. Thanks for your thoughts.
  • steve71: @Cokeman1959 $AKRX Sold 90% of my position yesterday, as posted. (Also $ACAD, $ANIP) There may have been some takeover speculation baked into the price. I am planning to re-enter the position sometime after Thursday (8/4) earnings.
  • steve71: $ACAD $ANIP $AKRX All report 8/4. I have been selling these positions down all morning, locking in profits. Plan to enter earnings at 10% long on all three. Acadia, in particular, is a short term risk. There are two important issues. This will be the first quarter of Nuplazid PDP sales results. If initial acceptance is slow, look out below. Second is commentary re the ADP trial, Nuplazid for Alzheimer's. My opinion is that Nuplazid for Parkinson's is fully priced in, and the company needs another disease to treat.
  • woodman: @steve71 $ACAD $ANIP $AKRX Thanks.
  • issues: @steve71 $ACAD $ANIP $AKRX Just looking at the charts, the one that is more "consistent" in its uptrend is ANIP, then AKRX and finally ACAD. I need to do a little more home work before deciding. Do you own any? Love that "Bob Marley" look-alike- picture you so proudly display. Great picture! Love it!!!
  • steve71: @issues $ACAD $ANIP $AKRX Hi issues. Just holding marker positions in all three until after earnings. Yah mon.
  • steve71: @woodman $AKRX $ANIP Yup. Akorn and Ani Pharma trading in tandem. Ani had suspiciously high volume the last couple of days.
  • woodman: @steve71 $AKRX $ANIP $AKRX is on my short list for buyouts. Hey, your $ACAD looks interesting here as well.
  • steve71: @woodman $AKRX $ANIP $ACAD My biotech portfolio is Triple A. I closed 90% of the Acadia position in the early June run up. As you know, Acadia has only one drug on the market. Pimavanserin is approved for Parkinson's psychosis (PDP). That's a reasonable size market and could eventually yield $1.0B to $1.5B in yearly sales. But Acadia trades on buyout speculation. That level of sales won't support a takeout price much above $30. The big prize is potential Pima use in Alzheimer's. That market is huge and growing. Acadia has two P2 Alzheimer's studies going. The first (P2-019) could read out late this year. I expect to see the stock run in anticipation of those results. I kinda have doubts about how good the results will be.
  • steve71: $ANIP Ani Pharma, mentioned yesterday, up 4% on strong volume. I can't find any news, other than a couple of upgrades.
  • steve71: $ANIP BTO $55.82. Above average volume. Just added another FDA approval.
  • steve71: $ANIP STC @ 48.80
  • steve71: $ACAD $ANIP $XBI $IBB Acadia and Ani are widely outperforming the biotech indices. Approval for Acadia's Pimavanserin is imminent, and presumably the PPS driver. I'm probably going to do a further Buy-Write at the close. Ani has spiked since I me ...
  • woodman: @steve71 $ACAD $ANIP $XBI $IBB - The Assurex IPO sounds very interesting. Thanks for mentioning and, if you can, please post again when we get closer.
  • steve71: $ANIP Mentioned last week. I opened just a 20% position at 41.20 because it seemed extended. Now it's more extended, benefitting from upgrades and price target raises.
  • steve71: $ANIP $ANIP is one of the few pharma/biotechs in the green today. IF you believe that pharma takeouts will increase, $ANIP is interesting. Barron’s has favorably covered Ani Pharmaceuticals 6/2015 and 10/2015. The company has earnings (!), and sells dozens of common branded and generic meds. This is not a cutting edge, high risk/reward biotech play. But they have a pipeline of 45 drugs, and regularly get FDA approvals. 20% margins, good growth and PEG 0.72, and $13.50/share in cash. Market cap is only $470M, maybe too small for big pharma to consider. I just opened a 20% position around 41.20. Using Dan’s “pullback to congestion” approach, a bounce off 37 would be a good place to go full long.
  • DAN: @steve71 $ANIP ...IF the stock falls to $37...or $36...wouldn't be a bullish thing. Needs to be an obvious "buy the dip" chart. You need to SEE it.
  • steve71: $ANIP ANI Pharmaceuticals. Subject of a favorable Barron's article 6/2015, when it was trading at 72. Cratered to 40 in the Hillary snit biotech meltdown. Now trading above the 50 dma. 45 products in pipeline, with frequent FDA approvals $15/share in cash. Earnings growth 30%. Opened my position two weeks ago at 44, and adding as it rises. LTH.
  • Lrd123: $ANIP showing a little green
  • issues: @Photiosm $ANIP may be better than $ANIK ?
  • Jadee: $ANIP Watching
  • issues: @woodman $BWP This is a bit of a mystery to me. $BWP beat est. by 43% (.16 to .23) HUGE!! yet the price is up less than 5%. Maybe tomorrow it jumps? Another mystery: $ANIP misses HUGE (-.01 to -.21) yet the crazy thing jumps 11%. The final Twilight Zone is $KORS Beat by 12% (.81 to l91) yet it's down 6%. I can just hear Ron Sterling coming in, "These things happen in the parallel universe called the Twilight ZOne..." then the music... (We are still watching Twilight Zone on Netflicks.
  • issues: Bought today! $JCP (It's a good buy point with a stop at $8.39.) Added to $AKRX $ANIP $SDRL. Thanks for those who participate and give good info to ACT on!!
Visit the Trading Forum to join in the discussion.
Stock Price $69.13
Change -0.80%
Volume 252,152

ANI Pharmaceuticals Inc is a specialty pharmaceutical company engaged in the development of products for female sexual health, menopause, contraception and male hypogonadism.

Request Video of ANIP
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!